CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 112 enrolled
Drug / intervention
Qi-tonifying Chinese herbal productsdrug
Likely dose
Qi-tonifying Chinese herbal products 500mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01631032
NCT01631032Phase 3Completed
CompareCT.gov

Phase 3 Study of Qi-tonifying Chinese Herbal Products for Treatment of Allergic Rhinitis

Chang Gung Memorial Hospital·interventional·Posted Jun 28, 2012·Updated Aug 7, 2015

In Brief

A Phase 3 clinical trial evaluating Qi-tonifying Chinese herbal products for Allergic Rhinitis. Completed, enrolled 112 participants across 1 site.

Detailed Summary

Allergic rhinitis is a common but complicated immunologic disorder disease and multiple western medicine has been used for symptom control. Chinese herbal medicine, one of the most commonly used complementary and alternative medicine in Taiwan, has also be used for allergic rhinitis control. This study is designed to explore the efficacy and possible underlying immune-modulation effect of the BZYQT, which is one of the most famous Chinese herbal medicine used for allergic rhinitis in daily practice.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAllergic Rhinitis
CountriesTaiwan
CollaboratorsCommittee on Chinese Medicine and Pharmacy

Timeline

Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 28, 2012
Enrollment StartJul 1, 2012
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 14.0 years ago

Interventions

Qi-tonifying Chinese herbal productsdrug

Chinese herbal products in capsule, 3 times a day, 3gm (6PC of 500mg capsule) each time, total 9gm per day